XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2020   $ 6 $ 400,071 $ (746) $ (366,072) $ 33,259
Balance (in shares) at Dec. 31, 2020 573,282 6,246,896        
Issue of common stock and associated warrants on underwritten offering, net of expenses   $ 2 13,499     13,501
Issue of common stock and associated warrants on underwritten offering, net of expenses (in shares)   2,078,214        
Warrant Exercises   $ 1 4,544     4,545
Warrant Exercises (in shares)   909,000        
Stock-based compensation     255     255
Preferred stock dividends     (50)     (50)
Unrealized foreign exchange on intercompany loans       1,599   1,599
Translation adjustment       (1,583)   (1,583)
Loss for the period         (3,478) (3,478)
Balance at Mar. 31, 2021   $ 9 418,319 (730) (369,550) 48,048
Balance (in shares) at Mar. 31, 2021 573,282 9,234,110        
Balance at Dec. 31, 2020   $ 6 400,071 (746) (366,072) 33,259
Balance (in shares) at Dec. 31, 2020 573,282 6,246,896        
Unrealized foreign exchange on intercompany loans           (2,903)
Translation adjustment           2,896
Loss for the period           (13,593)
Balance at Sep. 30, 2021   $ 10 421,771 (753) (379,664) 41,364
Balance (in shares) at Sep. 30, 2021 573,282 9,797,735        
Balance at Mar. 31, 2021   $ 9 418,319 (730) (369,550) 48,048
Balance (in shares) at Mar. 31, 2021 573,282 9,234,110        
Stock-based compensation     279     279
Preferred stock dividends     (50)     (50)
Unrealized foreign exchange on intercompany loans       941   941
Translation adjustment       (869)   (869)
Loss for the period         (5,127) (5,127)
Balance at Jun. 30, 2021   $ 9 418,548 (658) (374,677) 43,222
Balance (in shares) at Jun. 30, 2021 573,282 9,234,110        
Issue of common stock on At Market Issuance sales agreement, net of expenses   $ 1 2,954     2,955
Issue of common stock on At Market Issuance sales agreement, net of expenses (in shares)   563,625        
Expenses paid in connection with an At Market issuance sales agreement   $ 1 2,954     2,955
Expenses paid in connection with an At Market issuance sales agreement (in shares)   563,625        
Stock-based compensation     319     319
Preferred stock dividends     (50)     (50)
Unrealized foreign exchange on intercompany loans       (5,443)   (5,443)
Translation adjustment       5,348   5,348
Loss for the period         (4,987) (4,987)
Balance at Sep. 30, 2021   $ 10 421,771 (753) (379,664) 41,364
Balance (in shares) at Sep. 30, 2021 573,282 9,797,735        
Balance at Dec. 31, 2021   $ 10 422,960 (748) (384,959) 37,263
Balance (in shares) at Dec. 31, 2021 573,282 9,993,135        
Stock-based compensation     380     380
Preferred stock dividends     (50)     (50)
Unrealized foreign exchange on intercompany loans       (5,878)   (5,878)
Translation adjustment       5,803   5,803
Loss for the period         (4,108) (4,108)
Balance at Mar. 31, 2022   $ 10 423,290 (823) (389,067) 33,410
Balance (in shares) at Mar. 31, 2022 573,282 9,993,135        
Balance at Dec. 31, 2021   $ 10 422,960 (748) (384,959) 37,263
Balance (in shares) at Dec. 31, 2021 573,282 9,993,135        
Unrealized foreign exchange on intercompany loans           (40,390)
Translation adjustment           39,392
Loss for the period           (13,779)
Balance at Sep. 30, 2022   $ 9 422,542 (1,746) (398,738) 22,067
Balance (in shares) at Sep. 30, 2022 573,282 9,422,089        
Balance at Mar. 31, 2022   $ 10 423,290 (823) (389,067) 33,410
Balance (in shares) at Mar. 31, 2022 573,282 9,993,135        
Issue of common stock on At Market Issuance sales agreement, net of expenses   $ 1 1,524     1,525
Issue of common stock on At Market Issuance sales agreement, net of expenses (in shares)   1,339,742        
Expenses paid in connection with an At Market issuance sales agreement   $ 1 1,524     1,525
Expenses paid in connection with an At Market issuance sales agreement (in shares)   1,339,742        
Stock-based compensation     350     350
Stock-based awards (in shares)   17,412        
Preferred stock dividends     (50)     (50)
Unrealized foreign exchange on intercompany loans       (16,168)   (16,168)
Translation adjustment       15,715   15,715
Loss for the period         (4,575) (4,575)
Balance at Jun. 30, 2022   $ 11 425,114 (1,276) (393,642) 30,207
Balance (in shares) at Jun. 30, 2022 573,282 11,350,289        
Issue of common stock on At Market Issuance sales agreement, net of expenses   $ 1 1,581     1,582
Issue of common stock on At Market Issuance sales agreement, net of expenses (in shares)   1,188,900        
Reclassification of redeemable common stock   $ (3) (4,491)     (4,494)
Reclassification of redeemable common stock (in shares)   (3,117,100)        
Expenses paid in connection with an At Market issuance sales agreement   $ 1 1,581     1,582
Expenses paid in connection with an At Market issuance sales agreement (in shares)   1,188,900        
Stock-based compensation     388     388
Preferred stock dividends     (50)     (50)
Unrealized foreign exchange on intercompany loans       (18,344)   (18,344)
Translation adjustment       17,874   17,874
Loss for the period         (5,096) (5,096)
Balance at Sep. 30, 2022   $ 9 $ 422,542 $ (1,746) $ (398,738) $ 22,067
Balance (in shares) at Sep. 30, 2022 573,282 9,422,089